Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
- 21 April 2009
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 15 (3), 639-658
- https://doi.org/10.1111/j.1365-2516.2008.01950.x
Abstract
Although most surgical and invasive procedures can be performed safely in patients with haemophilia, the optimal level and duration of replacement therapy required to prevent bleeding complications have not been established conclusively. For providing more insight into optimal therapy during invasive procedures, a literature review of surgical procedures in patients with haemophilia was conducted. Concomitantly, current practice was surveyed in 26 European Haemophilia Comprehensive Care Centres, representing 15 different countries. The review identified 110 original papers published between 1965 and 2007. Of these, only two studies were randomized controlled trials. Target levels and the duration of replacement therapy in the published studies were as follows. For major orthopaedic surgery: preoperative targets were 80-90%; postoperative targets showed a high degree of variation, with trough levels ranging from 20% to 80%, duration 10-14 days; for liver biopsy, 70-100%, 1-7 days; tonsillectomy: 90-100%, 5-11 days; indwelling venous access device insertion: 100%, 3-10 days; circumcision: 50-60%, 2-4 days; dental surgery: 30-50%, single treatment. With the exception of dental surgery, current practice in Europe, as assessed by the survey, was largely in agreement with published data. In conclusion, this study provides both a comprehensive review and a large survey of replacement therapy in patients with haemophilia undergoing invasive procedures; these data have informed the consensus practical treatment recommendations made in this paper. This study highlights the need for better-designed studies in order to better define minimal haemostatic levels of replacement therapy and optimal treatment durationKeywords
This publication has 103 references indexed in Scilit:
- Use of recombinant factor IX in subjects with haemophilia B undergoing surgeryHaemophilia, 2002
- Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experienceHaemophilia, 1997
- ENT surgery in children with inherited bleeding disordersThe Journal of Laryngology & Otology, 1996
- Use of central venous catheters in children with severe congenital coagulopathyBritish Journal of Haematology, 1995
- Subcutaneous infusion ports in the pediatric patient with hemophiliaJournal of Pediatric Surgery, 1994
- Adenotonsillectomy in patients with inherited bleeding disordersClinical Otolaryngology, 1993
- Oral surgery in patients with hereditary bleeding disorders: A survey of treatment in the Stockholm area (1974–1985)International Journal of Oral & Maxillofacial Surgery, 1989
- Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgeryJournal of Oral and Maxillofacial Surgery, 1986
- PERCUTANEOUS LIVER BIOPSY AND CHRONIC LIVER DISEASE IN HÆMOPHILIACSThe Lancet, 1978
- FURTHER EXPERIENCE IN USE OF HUMAN ANTIHÆMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTION IN HÆMOPHILIC PATIENTS: A REPORT TO THE MEDICAL RESEARCH COUNCIL'S WORKING PARTY ON HUMAN ANTIHÆMOPHILIC GLOBULINThe Lancet, 1965